Mr. Henderson brings nearly 30 years of financial, commercial and pharmaceutical industry expertise to the board, most recently serving for almost 10 years as chief financial officer of $100 billion health care products and services company, Cardinal Health. Mr. Henderson served as CFO of Cardinal Health from 2005 until the end of 2014, playing a key role in the company’s growth and transformation. During his tenure, the company acquired more than 30 companies, spun-off or sold multi-billion-dollar businesses and expanded into new geographies and market segments. In addition to his financial responsibilities, Mr. Henderson managed commercial operations in China and Canada. Prior to Cardinal Health, Mr. Henderson was president and general manager of Eli Lilly Canada Inc. and vice president and corporate controller of Eli Lilly & Co. He joined Lilly in 1998 as vice president and corporate treasurer. His prior experience included 10 years at General Motors Corp., where he served in managerial posts in Great Britain, Singapore, New York and Canada. He received his Bachelor of Science degree in electrical engineering from Kettering University, Flint, Mich., and his Master of Business Administration degree from Harvard Graduate School of Business Administration. Mr. Henderson serves on the board of directors of Qualcomm, Inc., Fibrogen, Inc., and Becton Dickinson and Company. He serves on the Halozyme Compensation Committee and is the Chair of the Audit Committee.